EUS-Guided Biopsy with a Novel Puncture Biopsy Forceps Needle—Feasibility Study

• Main Authors: Geke Litjens, Christian Gerges, Yogesh M. Shastri, Piyush Somani, Torsten Beyna, Horst Neuhaus, Cornelis J. H. M. van Laarhoven, Mathias Prokop, Peter D. Siersema, John J. Hermans, Erwin J. M. van Geenen
• Format: Article
• Language: English
• Published: MDPI AG 2021-09-01
• Series: Diagnostics
• Subjects: endoscopic ultrasound; image-guided biopsy; biopsy; EUS-guided tissue acquisition; diagnostic accuracy
• Online Access: https://www.mdpi.com/2075-4418/11/9/1638

Endoscopic ultrasound (EUS) with fine needle aspiration (FNA) or biopsy (FNB) to diagnose lesions in the gastrointestinal tract is common. Demand for histology sampling to identify treatment-specific targets is increasing. Various core biopsy FNB needles to obtain tissue for histology are currently available, however, with variable (37–97%) histology yields. In this multicenter study, we evaluated performance, safety, and user experience of a novel device (the puncture biopsy forceps (PBF) needle). Twenty-four procedures with the PBF needle were performed in 24 patients with a suspected pancreatic lesion (<i>n</i> = 10), subepithelial lesion (<i>n</i> = 10), lymph node (<i>n</i> = 3), or pararectal mass (<i>n</i> = 1). In 20/24 (83%) procedures, the PBF needle yielded sufficient material for interpretation (sample adequacy). In 17/24 (71%), a correct diagnosis was made with the material from the PBF needle (diagnostic accuracy). All participating endoscopists experienced a learning curve. (Per)procedural technical issues occurred in four cases (17%), but there were no adverse events. The PBF needle is a safe and potentially useful device to obtain an EUS-guided biopsy specimen. As the design of the PBF needle is different to core biopsy FNB needles, specific training will likely further improve the performance of the PBF needle. Furthermore, the design of the needle needs further improvement to make it more robust in clinical practice.